3 weeks Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs Investor's Business Daily

Amgen stock rose early Wednesday, though the biotech behemoth said the FDA placed one of its obesity treatments on clinical hold.
The post Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs appeared first on Investor's Business Daily.